Business Information
The group's principal activity is to develop products that integrate advanced microelectronics and molecular biology. These products are used in the fields of biomedical research, genomics, medical diagnostics, genetic testing, drug discovery, forensics, agriculture and environmental testing. The group's products include the nanochip(R) system consisting of nanochip(R) molecular biology workstation and the nanochip(R) cartridge which enables identification and precision analysis of biological test samples containing charged molecules. Its products are marketed primarily in the United States, Europe and Mexico. The group has collaborative alliances with hitachi, ltd, aventis and becton dickinson. On 21-Apr-2004, the group acquired synx pharma inc.
|
|
Name |
Title
|
Email
|
| Howard Birndorf | Chmn., CEO, Company Founder | N/A | | David Ludvigson | COO, Pres. | N/A | | Robert Saltmarsh | CFO | Available | | Carl Foster | VP - Alliance Management | N/A | | David Boudreau | VP - Operations | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 26,852 | (49,070) | | 2005 | 12,544 | (96,494) | | 2004 | 5,374 | (38,907)
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
